Trial results will tell the full story. Well actually only half the story because it’s an open-label trial, that is not randomised and not blind.
I like your optimism but to say that the trial must be going great guns because it’s still going is a stretch.
The usual suspects were saying the exact same thing about DEP-Docetaxel for 5 long years after it was originally due to finish in 2018. Look how that turned out.
Same theme for DEP-Cabazitaxel.
Yet here we are at 13 cents. The market has spoken.
- Forums
- ASX - By Stock
- Ann: Half Yearly Report and Accounts
Trial results will tell the full story. Well actually only half...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.4¢ |
Change
0.001(1.08%) |
Mkt cap ! $38.76M |
Open | High | Low | Value | Volume |
9.4¢ | 9.4¢ | 9.4¢ | $829 | 8.824K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 249999 | 9.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 5000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 249999 | 0.093 |
2 | 70900 | 0.090 |
2 | 147200 | 0.087 |
1 | 6395 | 0.086 |
3 | 86000 | 0.085 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 5000 | 1 |
0.096 | 50000 | 1 |
0.097 | 60000 | 1 |
0.098 | 65000 | 1 |
0.099 | 48700 | 1 |
Last trade - 12.01pm 08/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |